Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Journal of Pediatric Endocrinology and Metabolism

Editor-in-Chief: Kiess, Wieland

Ed. by Bereket, Abdullah / Darendeliler, Feyza / Dattani, Mehul / Gustafsson, Jan / Luo, Fei Hong / Mericq, Veronica / Ogata, Tsutomu / Toppari, Jorma

12 Issues per year


IMPACT FACTOR 2017: 1.086

CiteScore 2017: 1.07

SCImago Journal Rank (SJR) 2017: 0.465
Source Normalized Impact per Paper (SNIP) 2017: 0.580

Online
ISSN
2191-0251
See all formats and pricing
More options …
Volume 30, Issue 2

Issues

Bone mineral density and bone metabolic markers’ status in children with neurofibromatosis type 1

Hatice Gamze Poyrazoğlu
  • Corresponding author
  • Assistant Professor of Pediatrics, Medical School of Firat University, Department of Pediatrics, Division of Pediatric Neurology, 23119 Elazig, Turkey
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Veysel Nijat Baş
  • Department of Pediatrics, Division of Pediatric Endocrinology, Eskisehir State Hospital, Eskisehir, Turkey
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Alev Arslan
  • Baskent University Medical Faculty Adana Medical and Research Center, Division of Pediatric Cardiology, Adana, Turkey
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Funda Bastug
  • Department of Pediatrics, Division of Pediatric Nephrology, Kayseri Training and Research Hospital, Kayseri, Turkey
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Mehmet Canpolat
  • Department of Pediatrics, Division of Pediatric Neurology, Erciyes University, Faculty of Medicine, Kayseri, Turkey
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Hüseyin Per
  • Department of Pediatrics, Division of Pediatric Neurology, Erciyes University, Faculty of Medicine, Kayseri, Turkey
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Hakan Gümüs
  • Department of Pediatrics, Division of Pediatric Neurology, Erciyes University, Faculty of Medicine, Kayseri, Turkey
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Sefer Kumandas
  • Department of Pediatrics, Division of Pediatric Neurology, Erciyes University, Faculty of Medicine, Kayseri, Turkey
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2017-01-26 | DOI: https://doi.org/10.1515/jpem-2016-0092

Abstract

Background:

Neurofibromatosis type 1 (NF1) is a multisystem disorder characterized by progressive manifestations, which is inherited in an autosomal dominant manner. The majority of patients with NF1 experience a diffuse, significant reduction in bone mass over time, with osteoporosis, osteopenia in the absence of severe scoliosis, or gross bone deformities. This study aimed to determine the bone mineral density (BMD) status, evaluate bone metabolism, and to determine the relevant factors in children with NF1.

Methods:

The study population included 33 pediatric NF1 patients (20 males and 13 females). Bone metabolic markers, such as total calcium, phosphorus, magnesium, alkaline phosphatase, parathyroid hormone, and 25-OH vitamin D, the urinary calcium/creatine ratio were measured. In addition, BMD was measured at both the lumbar spine (LS) and the femoral neck in all the patients.

Results:

All the patients had a low 25-OH vitamin D level, but it was significantly lower in the females than in the males (p<0.009). Overall, 18.2% of the patients had skeletal abnormalities. The lumbar Z-score was ≤2 in 21.2% of the patients, whereas the femoral neck Z-score was ≤2 in 9.1%. The urinary calcium/creatine ratio was significantly higher in the female than in the male patients (p<0.027). In all, six patients had skeletal abnormalities.

Conclusions:

It is widely known that bone mineral metabolism markers and BMD are significantly affected in NF1 patients; however, the present study did not identify any effective parameters that could be used to predict skeletal abnormalities, or diagnose early osteoporosis and osteopenia in pediatric NF1 patients.

Keywords: bone mineral density; bone mineral markers; children; neurofibromatosis type-1; osteoporosis

References

  • 1.

    Riccardi VM, Womack JE, Jacks T. Neurofibromatosis and related tumors. Natural occurrence and animal models. Am J Pathol 1994;145:994–1000.Google Scholar

  • 2.

    Vitale MG, Guha A, Skaggs DL. Orthopaedic manifestations of neurofibromatosis in children: an update. Clin Orthop Relat Res 2002;401:107–18.Google Scholar

  • 3.

    Cichowski K, Jacks T. NF- 1 tumor suppressor gene function: narrowing the GAP. Cell 2001;104:593–604.Google Scholar

  • 4.

    Petramala L, Giustini S, Zinnamosca L, Marinelli C, Colangelo L, et al. Bone mineral metabolism in patients with neurofibromatosis type 1 (von Recklinghausen disease). Arch Dermatol Res 2012;304:325–31.Google Scholar

  • 5.

    Hockett CW, Eelloo J, Huson SM, Roberts SA, Berry JL, et al. Vitamin D status and muscle function in children with neurofibromatosis type 1 (NF1). J Musculoskelet Neuronal Interact 2013;13:111–9.Google Scholar

  • 6.

    Brunetti-Pierri N, Doty SB, Hicks J, Phan K, Mendoza-Londono R, et al. Generalized metabolic bone disease in Neurofibromatosis type I. Mol Genet Metab 2008;94:105–11.Google Scholar

  • 7.

    Dulai S, Briody J, Schindeler A, North KN, Cowell CT, et al. Decreased bone mineral density in neurofibromatosis type 1: results from a pediatric cohort. J Pediatr Orthop 2007;27:472–5.Google Scholar

  • 8.

    Illes T, Halmai V, de Jonge T, Dubousset J. Decreased bone mineral density in neurofibromatosis-1 patients with spinal deformities. Osteoporos Int 2001;12:823–7.Google Scholar

  • 9.

    Kuorilehto T, Pöyhönen M, Bloigu R, Heikkinen J, Väänänen K, et al. Decreased bone mineral density and content in neurofibromatosis type 1: lowest local values are located in the load-carrying parts of the body. Osteoporosis Int 2005;16:928–36.Google Scholar

  • 10.

    Lammert M, Kappler M, Mautner VF, Lammert K, Störkel S, et al. Decreased bone mineral density in patients with neurofibromatosis 1. Osteoporos Int 2005;16:1161–6.Google Scholar

  • 11.

    Yang FC, Chen S, Robling AG, Yu X, Nebesio TD, et al. Hyperactivation of p 21ras and p13k cooperate to alter murine and human neurofibromatosis type 1-haploinsufficient osteoclast functions. J Clin Invest 2006;116:2880–91.Google Scholar

  • 12.

    Wu X, Estwick SA, Chen S, Yu M, Ming W, et al. Neurofibromin plays a critical role in modulating osteoblast differentiation of mesenchymal stem/progenitor cells. Hum Mol Genet 2006;15:2837–45.Google Scholar

  • 13.

    Crawford AH, Schorry EK. Neurofibromatosis in children: the role of orthopaedist. J Am Acad Orthop Surg 1999;7:217–30.Google Scholar

  • 14.

    Gutmann DH, Aylsworth A, Carey JC, Korf B, Marks J, et al. The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. J Am Med Assoc 1997;278:51–7.Google Scholar

  • 15.

    Goksen D, Darcan S, Coker M, Kose T. Bone mineral density of healthy Turkish children and adolescents. J Clin Densitom 2006;9:84–0.Google Scholar

  • 16.

    Writing group fort the ISCD position development conference. Diagnosis of osteoporosis in men, premenopausal woman, and children. J Clin Densitom 2004;7:17–6.Google Scholar

  • 17.

    Stevenson DA, Moyer-Mileur LJ, Murray M, Slater H, Sheng X, et al. Bone mineral density in children and adolescents with neurofibromatosis type 1. J Pediatr 2007;150:83–8.Google Scholar

  • 18.

    Seitz S, Schnabel C, Busse B, Schmidt HU, Beil FT, et al. High bone turnover and accumulation of osteoid in patients with neurofibromatosis 1. Osteoporos Int 2010;21:119–27.Google Scholar

  • 19.

    Kühnisch J, Seto J, Lange C, Schrof S, Stumpp S, et al. Multiscale, converging defects of macro-porosity microstructure and matrix mineralization impact long bone fragility in NF1. PLoS One 2014;9:e86115.Google Scholar

  • 20.

    Duman O, Ozdem S, Turkkahraman D, Olgac ND, Gungor F, et al. Bone metabolism markers and bone mineral density in children with neurofibromatosis type-1. Brain Dev 2008;30:584–8.Google Scholar

  • 21.

    Yilmaz K, Ozmen M, Bora Goksan S, Eskiyurt N. Bone mineral density in children with neurofibromatosis 1. Acta Paediatr 2007;96:1220–2.Google Scholar

  • 22.

    Lammert M, Friedman JM, Roth HJ, Friedrich RE, Kluwe L, et al. Vitamin D deficiency associated with number of neurofibromas in neurofibromatosis 1. J Med Genet 2006;43:810–3.Google Scholar

About the article

Corresponding author: Hatice Gamze Poyrazoğlu, MD, Assistant Professor of Pediatrics, Medical School of Firat University, Department of Pediatrics, Division of Pediatric Neurology, 23119 Elazig, Turkey, Phone: +90 424 233 3555-2330


Received: 2016-03-10

Accepted: 2016-11-21

Published Online: 2017-01-26

Published in Print: 2017-02-01


Author contributions: PHG conceived the study, BVN, GH, and PH reviewed the literature, PHG, BVN, GH, PH, CM and KS were involved in patients care, including the process of procedure and routine clinical follow-up, AA, BF made helpful collection of data, PHG and AA performed literature review and written manuscript. BF, CM, and KS reviewed the manuscript. All authors were responsible for patient management. All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

Research funding: None declared.

Employment or leadership: None declared.

Honorarium: None declared.

Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.


Citation Information: Journal of Pediatric Endocrinology and Metabolism, Volume 30, Issue 2, Pages 175–180, ISSN (Online) 2191-0251, ISSN (Print) 0334-018X, DOI: https://doi.org/10.1515/jpem-2016-0092.

Export Citation

©2017 Walter de Gruyter GmbH, Berlin/Boston.Get Permission

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Anna Hagner, Agata Marjańska, Magdalena Dziedzic, Agnieszka Jatczak-Gaca, Jan Styczyński, Bartosz Romańczuk, Grażyna Odrowąż-Sypniewska, and Mariusz Wysocki
Pediatria Polska, 2017

Comments (0)

Please log in or register to comment.
Log in